Search by Drug Name or NDC
NDC 16571-0139-50 Atorvastatin Calcium 80 mg/1 Details
Atorvastatin Calcium 80 mg/1
Atorvastatin Calcium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharma Holdings, Inc.. The primary component is ATORVASTATIN CALCIUM TRIHYDRATE.
MedlinePlus Drug Summary
Atorvastatin is used together with diet, weight loss, and exercise to reduce the risk of heart attack and stroke and to decrease the chance that heart surgery will be needed in people who have heart disease or who are at risk of developing heart disease. Atorvastatin is also used to decrease the amount of fatty substances such as low-density lipoprotein (LDL) cholesterol ('bad cholesterol') and triglycerides in the blood and to increase the amount of high-density lipoprotein (HDL) cholesterol ('good cholesterol') in the blood. Atorvastatin may also be used to decrease the amount of cholesterol and other fatty substances in the blood in children and teenagers 10 to 17 years of age who have familial heterozygous hypercholesterolemia (an inherited condition in which cholesterol cannot be removed from the body normally). Atorvastatin is in a class of medications called HMG-CoA reductase inhibitors (statins). It works by slowing the production of cholesterol in the body to decrease the amount of cholesterol that may build up on the walls of the arteries and block blood flow to the heart, brain, and other parts of the body. Accumulation of cholesterol and fats along the walls of your arteries (a process known as atherosclerosis) decreases blood flow and, therefore, the oxygen supply to your heart, brain, and other parts of your body. Lowering your blood level of cholesterol and fats with atorvastatin has been shown to prevent heart disease, angina (chest pain), strokes, and heart attacks.
Related Packages: 16571-0139-50Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Atorvastatin
Product Information
NDC | 16571-0139 |
---|---|
Product ID | 16571-139_3ce77d64-b08e-43b6-a3ab-3aca688f734a |
Associated GPIs | |
GCN Sequence Number | 045772 |
GCN Sequence Number Description | atorvastatin calcium TABLET 80 MG ORAL |
HIC3 | M4D |
HIC3 Description | ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS) |
GCN | 43723 |
HICL Sequence Number | 012404 |
HICL Sequence Number Description | ATORVASTATIN CALCIUM |
Brand/Generic | Generic |
Proprietary Name | Atorvastatin Calcium |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | atorvastatin calcium, film coated |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 80 |
Active Ingredient Units | mg/1 |
Substance Name | ATORVASTATIN CALCIUM TRIHYDRATE |
Labeler Name | Rising Pharma Holdings, Inc. |
Pharmaceutical Class | HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA209912 |
Listing Certified Through | 2024-12-31 |
Package
NDC 16571-0139-50 (16571013950)
NDC Package Code | 16571-139-50 |
---|---|
Billing NDC | 16571013950 |
Package | 500 TABLET in 1 BOTTLE (16571-139-50) |
Marketing Start Date | 2023-10-20 |
NDC Exclude Flag | N |
Pricing Information | N/A |